Carlyle joins $221m round for Japan's Spiber
The Carlyle Group’s Japan team has completed its first minority deal, participating as a cornerstone investor in a JPY24.4 billion ($221 million) round for local biomaterials developer Spiber.
It demonstrates a developing tendency among traditional buyout firms operating in Asia to embrace minority growth strategies amid a mix of incentives such as rising competition for assets, higher valuations,...
More on North Asia
Latest News
Hitachi sells radiation devices business to Nippon Mirae Capital
Hitachi has agreed to sell its Japan-based radiation measurement devices and industrial x-ray CT devices businesses to local private equity firm Nippon Mirae Capital.
MBK agrees $1b China theme park deal
MBK Partners has agreed to buy five ocean theme parks in China – four operational and one under construction – from Hong Kong-listed Haichang Ocean Park Holdings for RMB6.53 billion ($1.01 billion).
China's Trustar buys European EV charging specialist
Trustar Capital, formerly known as CITIC Capital Partners, has invested an undisclosed sum in Intramco, a Europe-based manufacturer of components used in electric vehicle (EV) charging.
China's Vitalbridge closes Fund II at $275m
Vitalbridge Capital, a China-based venture capital firm that spun out from Trustbridge Partners, has raised $275 million for its second US dollar-denominated fund.